Crossref
India: Doctors report surge in use of off label GLP-1 agonists among rich
BMJ · 2024
DOI: 10.1136/bmj.q1605 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMJ, 2024. Verfasst von Neeta Lal. Beteiligte Einrichtung: New Delhi. Hauptthemen laut MEDLINE: Off-Label Use, Hypoglycemic Agents. Die Arbeit nennt 2 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Off-Label UseHypoglycemic AgentsHumansIndiaGlucagon-Like Peptide 1Diabetes Mellitus, Type 2Practice Patterns, Physicians'
Substanzen
Hypoglycemic AgentsGlucagon-Like Peptide 1
Autor:innen und Institutionen
- New Delhi.
Zitieren
APA
Lal, N. (2024). India: Doctors report surge in use of off label GLP-1 agonists among rich. BMJ. https://doi.org/10.1136/bmj.q1605
Vancouver
Lal N. India: Doctors report surge in use of off label GLP-1 agonists among rich. BMJ. 2024. doi:10.1136/bmj.q1605
BibTeX
@article{Lal2024,
author = {Lal, Neeta},
title = {India: Doctors report surge in use of off label GLP-1 agonists among rich},
journal = {BMJ},
year = {2024},
doi = {10.1136/bmj.q1605}
}
EUVIMED